Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 1, 2007

Published online before print October 19, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow HTML Page - index.htslp
Right arrow All Versions of this Article:
jlb.0806517v1
81/2/557    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chun, S.-K.
Right arrow Articles by Kim, P.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chun, S.-K.
Right arrow Articles by Kim, P.-H.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0806517


Received for publication August 16, 2006.
Revised September 18, 2006.
Accepted for publication September 25, 2006.


Article

Mechanisms underlying TGF-{beta}1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis

Sung-Ki Chun *, Byung-Chul Chae *, Hyun-A Kim *, Goo-Young Seo *, Dong-Wan Seo *, Gie-Taek Chun *, Nam-Soo Kim *, Se-Won Yie *, Woo-Hyeon Byeon *, Seok-Hyun Eom *, Kwon-Soo Ha {dagger}, Young-Myeong Kim {dagger}, and Pyeung-Hyeun Kim *{dagger}@

*Department of Molecular Bioscience, School of Bioscience and Biotechnology, and {dagger}Vascular System Research Center, Kangwon National University, Chunchon, Korea

@ To whom correspondence should be addressed. E-mail: phkim{at}kangwon.ac.kr.


   Abstract

TGF-{beta} induces vascular endothelial growth factor (VEGF), a potent angiogenic factor, at the transcriptional and protein levels in mouse macrophages. VEGF secretion in response to TGF-{beta}1 is enhanced by hypoxia and by overexpression of Smad3/4 and hypoxia-inducible factor-1{alpha}/{beta} (HIF-1{alpha}/{beta}). To examine the transcriptional regulation of VEGF by TGF-{beta}1, we constructed mouse reporters driven by the VEGF promoter. Overexpression of HIF-1{alpha}/{beta} or Smad3/4 caused a slight increase of VEGF promoter activity in the presence of TGF-{beta}1, whereas cotransfection of HIF-1{alpha}/{beta} and Smad3/4 had a marked effect. Smad2 was without effect on this promoter activity, whereas Smad7 markedly reduced it. Analysis of mutant promoters revealed that the one putative HIF-1 and two Smad-binding elements were critical for TGF-{beta}1-induced VEGF promoter activity. The relevance of these elements was confirmed by chromatin immunoprecipitation assay. p300, which has histone acetyltransferase activity, augmented transcriptional activity in response to HIF-1{alpha}/{beta} and Smad3/4, and E1A, an inhibitor of p300, inhibited it. TGF-{beta}1 also increased the expression of fetal liver kinase-1 (Flk-1), a major VEGF receptor, and TGF-{beta}1 and VEGF stimulated pro-matrix metalloproteinase 9 (MMP-9) and active-MMP-9 expression, respectively. The results from the present study indicate that TGF-{beta}1 can activate mouse macrophages to express angiogenic mediators such as VEGF, MMP-9, and Flk-1.

Key Words: MMP-9 • HUVEC • promoter




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L. D. Moore, T. Isayeva, G. P. Siegal, and S. Ponnazhagan
Silencing of Transforming Growth Factor-{beta}1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo
Clin. Cancer Res., August 1, 2008; 14(15): 4961 - 4970.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H.-A Kim, S.-H. Jeon, G.-Y. Seo, J.-B. Park, and P.-H. Kim
TGF-{beta}1 and IFN-{gamma} stimulate mouse macrophages to express BAFF via different signaling pathways
J. Leukoc. Biol., June 1, 2008; 83(6): 1431 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. S.R. Maharaj, T. E. Walshe, M. Saint-Geniez, S. Venkatesha, A. E. Maldonado, N. C. Himes, K. S. Matharu, S. A. Karumanchi, and P. A. D'Amore
VEGF and TGF-{beta} are required for the maintenance of the choroid plexus and ependyma
J. Exp. Med., February 18, 2008; 205(2): 491 - 501.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Ishida, J.-L. Gao, and P. M. Murphy
Chemokine Receptor CX3CR1 Mediates Skin Wound Healing by Promoting Macrophage and Fibroblast Accumulation and Function
J. Immunol., January 1, 2008; 180(1): 569 - 579.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W.-L. Yeh, D.-Y. Lu, C.-J. Lin, H.-C. Liou, and W.-M. Fu
Inhibition of Hypoxia-Induced Increase of Blood-Brain Barrier Permeability by YC-1 through the Antagonism of HIF-1{alpha} Accumulation and VEGF Expression
Mol. Pharmacol., August 1, 2007; 72(2): 440 - 449.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Society for Leukocyte Biology.